Search Results - "Llibre JM"

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort.

Authors: Llibre, JM Montoliu, A Miró, JM et al.

Source: HIV Medicine. Mar2019, Vol. 20 Issue 3, p237-247. 11p.

Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.

Authors: Pedrol, E Llibre, JM Tasias, M et al.

Source: HIV Medicine. Nov2015, Vol. 16 Issue 10, p628-634. 7p.

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

Authors: Llibre, JM Bonjoch, A Iribarren, J et al.

Source: HIV Medicine. Aug2008, Vol. 9 Issue 7, p508-513. 6p. 2 Charts, 1 Graph.

Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance.

Authors: Llibre, JM Young, B

Source: HIV Medicine. Apr2014, Vol. 15 Issue 4, p193-195. 3p.

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens.

Authors: Santos JR Llibre JM Imaz A et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jun2012, Vol. 67 Issue 6, p1462-1469. 8p.

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.

Authors: Moltó J Llibre JM Ribera E et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). May2009, Vol. 63 Issue 5, p992-997. 6p.

URL: 39989155

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection.

Authors: Martin‐Iguacel, R Pedersen, C Llibre, JM et al.

Source: HIV Medicine. Jul2019, Vol. 20 Issue 6, p404-417. 14p.

Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259-264. Methodological accuracy in cross-trial comparisons of antiretroviral regimens in multitreated patients.

Authors: Llibre JM Pérez-Alvarez N

Source: HIV Medicine. Nov2007, Vol. 8 Issue 8, p568-570. 3p.

URL: 27092198

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice.

Authors: Llibre, JM Martínez, E Barreiro, P et al.

Source: Journal of the International AIDS Society. Nov2010 Supplement S3, Vol. 13, pP35-P35. 1p.

The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV.

Authors: Stellbrink, H‐J Lazzarin, A Woolley, I et al.

Source: HIV Medicine. Mar2020 Supplement S1, Vol. 21, p3-16. 14p.

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

Authors: Malin, JJ Boesecke, C Schwarze‐Zander, C et al.

Source: HIV Medicine. Mar2019, Vol. 20 Issue 3, p230-236. 7p.

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.

Authors: Winston, A Stöhr, W Antinori, A et al.

Source: HIV Medicine. Jun2016, Vol. 17 Issue 6, p471-478. 8p.

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of Anti Retroviral Treatment ( START) trial.

Authors: Baxter, JD Dunn, D White, E et al.

Source: HIV Medicine. Apr2015 Supplement, Vol. 16, p77-87. 11p.

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

Authors: Martínez E Arnaiz JA Podzamczer D et al.

Source: New England Journal of Medicine. 9/11/2003, Vol. 349 Issue 11, p1036-1046. 11p.

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.

Authors: Martinez-Picado J Negredo E Ruiz L et al.

Source: Annals of Internal Medicine. 7/15/2003, Vol. 139 Issue 2, p81-I16. 10p.

URL: 10246332

Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates.

Authors: Golf, JP Sala, L Aramburo, J et al.

Source: Journal of the International AIDS Society. Nov2010 Supplement S3, Vol. 13, pP67-P67. 2p.

From clinical research to public health action: addressing chronic female genital schistosomiasis in non-endemic countries.

Authors: Roure S Serrano L Vallès X et al.

Source: Parasitology [Parasitology] 2025 Dec; Vol. 152 (14), pp. 1471-1479.

Publication Type: Journal Article

Journal Info: Publisher: Cambridge University Press Country of Publication: England NLM ID: 0401121 Publication Model: Print Cited Medium: Internet ISSN: 1469-8161 (Electronic) Linking ISSN: 00311820 NLM ISO Abbreviation: Parasitology Subsets: MEDLINE

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Authors: Clemente T Stam AJ Elvstam O et al.

Corporate Authors: Clemente T Stam AJ Elvstam O et al.

Source: The lancet. HIV [Lancet HIV] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Persistent injection site nodule with subcutaneous long-acting cabotegravir and rilpivirine.

Authors: Álvarez H López-Solache L Gil-Pallares P et al.

Source: AIDS (London, England) [AIDS] 2026 Jun 01; Vol. 40 (6), pp. 866-868. Date of Electronic Publication: 2026 Apr 29.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE; In Process

Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.

Authors: Llibre JM Ripamonti D Geretti AM et al.

Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 May 20; Vol. 82 (5), pp. 785-798.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE